PRESCIENT THERAPEUTICS LIMITED - Charts / Financials

1.89%

5.2¢

Market Cap $41.87M

Healthcare Biotechnology

Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The... Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The Company is developing personalized medicine approaches to cancer, including targeted and cellular therapies. Its product pipeline includes PTX-100, PTX-200, OmniCAR, CellPryme-M and CellPryme-A. PTX-100 has completed Phase Ib expansion cohort study in relapsed and refractory T cell lymphomas. PTX-200 is a PH domain inhibitor that inhibits a tumor survival pathway, Akt. OmniCAR is a universal immune receptor platform being developed to enable controllable T-cell activity and multi-antigen targeting with a single-cell product. CellPryme-M technology enhances adoptive cell therapy performance by shifting T and NK cells towards a central memory phenotype, improving persistence, and increasing the ability to find and penetrate tumors. CellPryme-A is an adjuvant therapy designed to be administered to patients alongside cellular immunotherapy to help them overcome a suppressive tumor microenvironment.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

REFRESH

Day
Open	5.3¢		Day High	5.3¢		Day Low	4.9¢
Daily Volume	1024931

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
1	5.0¢	18678		1	5.2¢	50000

Directors & Senior Management

Mr. James Mcdonnell	Chief Executive Officer
Ms. Melanie Jaye Leydin	Chief Financial Officer, Company Secretary
Dr. Marissa Lim	Chief Medical Officer
Dr. James A. Campbell	Non-Executive Chairman of the Board
Dr. Allen James Ebens	Non-Executive Director
Ms. Melanie Farris	Non-Executive Director
Dr. Ellen Gwen Feigal	Non-Executive Independent Director
Dr. Gavin James Shepherd	Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 5.2¢		Change -0.001(1.89%)		Mkt cap ! $41.87M

Open	High	Low	Value	Volume
5.3¢	5.3¢	4.9¢	$51.46K	1.024M

Buyers (Bids)

No.	Vol.	Price($)
1	18678	5.0¢

Sellers (Offers)

Price($)	Vol.	No.
5.2¢	50000	1

View Market Depth

No.	Vol.	Price($)
2	338000	0.049
3	643749	0.048
3	260659	0.047
2	130239	0.046
2	131111	0.045

Price($)	Vol.	No.
0.052	50000	1
0.053	50000	1
0.055	100000	1
0.056	57000	2
0.057	200000	1

Last trade - 15.15pm 13/06/2025 (20 minute delay)

PTX (ASX) Chart

PRESCIENT THERAPEUTICS LIMITED - Charts / Financials

Corporate SpotlightNot Yet Available

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available